Twist Bioscience Corporation , a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025. Visit the Events ...
Shares of Twist Bioscience climbed after the company said it expects to post first-quarter revenue ahead of its previous guidance. The stock rose 8.1%, to $38.19, late Monday morning, but has fallen ...
inews.co.uk on MSN
The cheese health experts eat every week
Like all dairy, eggs, fish and meat, cottage cheese qualifies as a complete protein, supplying all nine essential amino acids ...
Skin with a "healthy glow" is officially the beauty industry's most-coveted aesthetic. Here is how two powerhouses achieved ...
A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...
Bacterial Conjunctivitis Drugs Market is expected to reach US$ 4.9 Billion by 2036, Driven by Increasing Prevalence of Eye ...
Brits plagued by forgetfulness are being told to get their vitamin levels checked, as running low on a crucial nutrient can ...
The NHS has warned that vitamin B12 deficiency can cause neurological problems that may mimic dementia symptoms ...
The intersection of high-concept Parisian tailoring and rugged Alpine performance is reaching a new peak this season. Later ...
The birth control pill contains the hormones estrogen and progestin, which prevent the monthly ovulation and provide women ...
Doctors at Duke University Hospital performed the first heart transplant of its kind, called donation after circulatory death ...
Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of ExcellenceBOSTON & MILAN--(BUSINESS WIRE)- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback